(NorthShore University HealthSystem) Ambry Genetics Corporation (Ambry), leaders in genetic testing, announced today the launch of AmbryScore for prostate cancer risk. This is the first polygenic risk score (PRS) test to predict lifetime risk of prostate cancer, developed in collaboration with NorthShore University HealthSystem's (NorthShore) Center for Personalized Medicine.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2Q4k1Um
No comments:
Post a Comment